GlassScriptPhysician profile
Christine A Swanson
NPI 1104428465
$2,193.30
in general payments reported to CMS, 2019-2025
11 companies · $1,982 in 2025
The $1,982 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.87 · 2024: $172 · 2025: $1,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,089 · Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,088.52 |
| Food and Beverage | $1,064.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,766.27 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $166.51 | 2021-2025 | Wainua |
| Alnylam Pharmaceuticals INC. | $56.44 | 2025 | Onpattro |
| Kestra Medical Technology Services, INC. | $48.93 | 2025 | Assure Wcd |
| Abiomed | $38.60 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.27 | 2024 | Livtencity |
| Novo Nordisk INC | $21.42 | 2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.66 | 2025 | Jardiance |
| Atricure, INC. | $18.51 | 2025 | Synergy Ablation System |
| Boston Scientific Corporation | $17.50 | 2025 | Watchman Flx |
| Horizon Therapeutics Plc | $15.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.